Cross-sectional, interventional, and causal investigation of insulin sensitivity using plasma proteomics in diverse populations

Pik Fang Kho,Neil Wary,Daniela Zanetti,Fahim Abbasi,Joshua Knowles,Daniel J. Panyard,Katie T Watson,Laurel Stell,Laura C Lazzeroni,Stefan Gustafsson,Lars Lind,John R Petrie,Themistocles L Assimes

DOI: https://doi.org/10.1101/2024.11.09.24317011

2024-11-12

Abstract:Background: We previously reported significant correlations between a direct measure of insulin sensitivity (IS) and blood levels of proteins measured using the Proximity Extension Assay (PEA) in two European cohorts. However, protein correlations with IS within non-European populations, in response to short-term interventions that improve IS, and any causal associations with IS have not yet been established. Methods: We measured 1,470 proteins using the PEA in the plasma of 1,015 research participants at Stanford University who underwent one or more direct measures of IS. Association analyses were carried out with multivariable linear regression within and across Stanford subgroups and within each of the two European cohorts. Association statistics were also meta-analyzed after transformation and harmonization of the two direct measures of IS. Lastly, we performed genome-wide association studies of IS and used genetic instruments of plasma proteins from the UK Biobank to identify candidate causal proteins for IS through Mendelian Randomization (MR) analysis. Results: In age and sex adjusted model, 810 proteins were associated with baseline IS among 652 self-reported European participants in the Stanford cohort at a false discovery rate (FDR) < 0.05. Effect sizes for these proteins were highly correlated with those observed in 122 South Asian, 92 East Asian, 85 Hispanic, and 52 Black/African American persons (r= 0.68 to 0.83, all P<=4.3x10^-113). Meta-analysis of the full Stanford cohort with the two European cohorts (N=2,945) yielded 247 significant protein associations (FDR < 0.05), with 75 remaining significant after further adjustment for body mass index. In a subset of Stanford participants undergoing insulin sensitizing interventions (N=53 taking thiazolidinediones, N=66 with weight loss), 79.6% of protein level changes were directionally consistent with the respective baseline association (observed/expected p=6.7x10^-16). MR analyses identified eight candidate causal proteins for IS, among which were SELE and ASGR1, proteins with established drug targets currently under investigation. Conclusion: Plasma proteins measured using the PEA provide a robust signature for IS across diverse populations and after short-term insulin sensitizing interventions highlighting their potential value as universal biomarkers of insulin resistance. A small subset of markers provided insights into potential causal molecular mechanisms and therapeutic targets.

Genetic and Genomic Medicine

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are:

1. **Consistency across populations**: Researchers hope to verify whether insulin - sensitivity (IS) - related proteins measured by plasma proteomics are consistent among different populations (especially non - European populations). Previous studies have mainly focused on European populations, while this study has been extended to multiple racial/ethnic groups including South Asians, East Asians, Hispanics, and African - Americans.

2. **Consistency after intervention**: Researchers also hope to evaluate the changes of these protein markers after short - term insulin - sensitizing interventions (such as using thiazolidinediones or losing weight) to determine whether they can track the changes in insulin sensitivity and thus serve as potential biomarkers for monitoring treatment effects.

3. **Causality**: Through Mendelian randomization (MR) analysis, researchers attempt to identify candidate proteins with potential causal relationships with insulin sensitivity. This helps to reveal the molecular mechanisms of insulin resistance and provides potential targets for developing new treatment methods.

### Main methods and results:
- **Methods**:
- **Cohort study**: The study utilized data from three cohorts: RISC, ULSAM, and Stanford study, among which the Stanford cohort included more diverse racial/ethnic backgrounds.
- **Proteomics analysis**: 1,470 proteins were measured using Proximity Extension Assay (PEA) technology.
- **Statistical analysis**: The associations between proteins and insulin sensitivity were analyzed by multivariate linear regression, and meta - analysis was performed to integrate data from different cohorts.
- **Intervention study**: The changes in protein levels were analyzed in a subset of participants who received insulin - sensitizing interventions.
- **Mendelian randomization analysis**: Two - sample MR analysis was performed using genetic instrumental variables to explore the causal relationships between proteins and insulin sensitivity.

- **Results**:
- **Consistency across populations**: After adjusting for age and sex, among 652 Stanford participants who self - reported as Europeans, 810 proteins were significantly associated with baseline insulin sensitivity (FDR < 0.05). The effect sizes of these proteins also showed high consistency in other racial/ethnic groups (correlation coefficient r = 0.68 to 0.83, P ≤ 4.3 × 10^-113).
- **Consistency after intervention**: Among 53 participants who received thiazolidinedione treatment and 66 participants who lost weight, 79.6% of the protein - level change directions were consistent with the baseline association directions (p = 6.7 × 10^-16).
- **Causality**: Through MR analysis, researchers identified 8 potential causal proteins, including SELE and ASGR1, which are targets of existing drugs.

### Conclusion:
This study provides a great deal of evidence indicating that plasma proteomics can be used as a robust marker of insulin sensitivity, applicable to different populations, and can also effectively track the changes in insulin sensitivity after short - term insulin - sensitizing interventions. In addition, the study also reveals some potential causal proteins, providing important clues for understanding the molecular mechanisms of insulin resistance and developing new treatment strategies.